FDA Inspection 1068341 — American Red Cross Biomedical Services Northern New England Region

American Red Cross Biomedical Services Northern New England Region — FEI 1273026

The FDA completed an inspection of American Red Cross Biomedical Services Northern New England Region on September 13, 2018 in Burlington, VT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Burlington, VT (United States)